Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Health & MedicineOne-Off1JManifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-PrognoseNein 77.9%
Prognostiker
14
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 12 Stunden
Veraltet21. Feb. 23, 20:23 UTC31. Dez. 27, 22:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Will FDA approve any mRNA vaccine against any type of human papillomavirus infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiAny vaccine against Alzheimer's disease to be safe and effective by the end of 2027?
FutuurWill the FDA approve a cure for Type 1 diabetes before 2033?
KalshiRegeln
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of any type of herpes simplex infection in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
Offene Märkte
Health & Medicine
POLYMARKETEbola pandemic in 2026?
- No+1.1pt97%
- Yes-1.1pt3%
- Gesamtvolumen
- 650.139,4 €
- 24h-Volumen
- 29.718,1 €
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Gesamtvolumen
- 15,6 Mio. €
- 24h-Volumen
- 20.486,4 €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 5178 €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt64%
- September+2.0pt41%
- June28%
- Gesamtvolumen
POLYMARKETNew pandemic in 2026?
- No93.1%
- Yes6.9%
- Gesamtvolumen
- 915.107,8 €
- 24h-Volumen
- 3244,5 €
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before 2027+8.0pt84%
- before April 202781%
- before December+1.0pt69%
+3 weitere Ergebnisse
- Gesamtvolumen
- 14.247,1 €
- Measles cases in 2026?
- New pandemic before 2028?
- Ebola pandemic in 2026?
- Will the FDA approve any psychedelic substance for medical use this year?
- Measles cases in U.S. in 2026?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA approves Retatrutide this year?
- Which countries will report an Ebola case in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Which countries will have an Ebola case in 2026?
Häufige Fragen
- Wie stehen die aktuellen Quoten für Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028??
- Manifold Markets bewertet No mit 78% (Stand: 8. September 2026).
- Wann wird Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028? entschieden?
- Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028? soll am 31. Dezember 2027 entschieden werden.
- Wie wird Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028? abgerechnet?
- Manifold Markets rechnet diesen Markt wie folgt ab: Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of any type of herpes simplex infection in the United States before January 1, 2028.